The Laboratorio de Hemoderivados of the National University of Córdoba, Argentinian Republic, celebrated its 50th anniversary on May 21st of 2014. Hemoderivados is the only plasma product manufacturer in Argentina 
and it is a role model in terms of nation-wide drug production. Its presence greatly improves access to key medical products for the Argentinian community, regulating market prices and replacing imports.
Laboratorio de Hemoderivados develops, manufactures and markets products that save and improve the lives of people with hemophilia, immune disorders, infectious diseases, kidney and liver disease, trauma, and other chronic and acute medical conditions. These products are used in many countries of the region such as Uruguay, Chile, Ecuador, Bolivia, Paraguay and the Dominican Republic. As a model State-owned non-profit corporation with successful economic and financial self-management, it has significantly diversified its production over the last 50 years, adding to the plasma-derived product line two other production lines: injectable drugs and a human tissue bank.
Laboratorio de Hemoderivados
Universidad Nacional de Córdoba
Av. Valparaíso s/n – Ciudad Universitaria
CP: X5000HRA – Córdoba Capital
T: 54 351 433 4122 / 23
F: 54 351 433 4124
E: laboratorio@hemo.unc.edu.ar
A roundup of some of the latest stories coming out of Latin American pharma and healthcare, including Merck’s new distribution centre in Brazil; the region’s record dengue surge; Roemmers Laboratory’s…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Mariana Abdala of Crystal Research outlines the vast room for improvement in Latin America’s clinical trial output, the region’s…
Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition of Shire in 2018 and divesting ‘non-core’ assets in OTC…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
While Bayer’s recent history has been dominated by the controversial Monsanto acquisition, the German firm will be hoping for a more straightforward next few years with a new leadership team…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
Axios International has been designing and implementing access to healthcare solutions in collaboration with the pharmaceutical industry and other healthcare players across Latin America (LatAm), Europe, the Middle East, Africa,…
Maria Gabriela Pittis, Head of SAM (South Cone, Andean Region, Mexico & Central America and Caribbean) at Takeda, outlines the company’s significant presence in the cluster, its double digit growth…
Florencia Davel, head of LatAm operations for Bristol Myers Squibb (BMS) looks back on a successful four years in position, shaping the regional organisation into a true biopharma player in…
The Head of Viatris Latin America, Patrick Doyle, spoke to PharmaBoardroom about setting up the two-year old company’s Latam affiliate during the pandemic, the decision to focus on specific therapeutic…
Boehringer Ingelheim’s managing director for South America, Dirk van Niekerk, provides an overview of the healthcare climate in South America, the challenges tied to political and economic instability, future opportunities…
Dr Guillermo Chantada, incoming president-elect of the International Society of Paediatric Oncology (SIOP) highlights the progress of paediatric oncology in Latin America and gives a call to arms to the…
See our Cookie Privacy Policy Here
